BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 806016)

  • 1. Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections.
    Shapiro WR; Young DF; Mehta BM
    N Engl J Med; 1975 Jul; 293(4):161-6. PubMed ID: 806016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral subarachnoid sampling of cerebrospinal fluid in the rhesus monkey.
    Bacher JD; Balis FM; McCully CL; Godwin KS
    Lab Anim Sci; 1994 Apr; 44(2):148-52. PubMed ID: 8028278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetics of intrathecal chemotherapy and clinical problems].
    Fujimoto T
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1536-42. PubMed ID: 6433796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate distribution within the subarachnoid space after intraventricular and intravenous administration.
    Balis FM; Blaney SM; McCully CL; Bacher JD; Murphy RF; Poplack DG
    Cancer Chemother Pharmacol; 2000; 45(3):259-64. PubMed ID: 10663645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood-brain barrier disruption in patients with brain lymphoma.
    Zylber-Katz E; Gomori JM; Schwartz A; Lossos A; Bokstein F; Siegal T
    Clin Pharmacol Ther; 2000 Jun; 67(6):631-41. PubMed ID: 10872645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of acute lymphocytic leukemia by high-dose intravenous methotrexate.
    Wang JJ; Freeman AI; Sinks LF
    Cancer Res; 1976 Apr; 36(4):1441-4. PubMed ID: 1063065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacology of intrathecal methotrexate. I. Pharmacokinetics in nontoxic patients after lumbar injection.
    Bleyer WA; Dedrick RL
    Cancer Treat Rep; 1977 Jul; 61(4):703-8. PubMed ID: 577895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of cerebrospinal fluid hypovolemia caused by Ommaya reservoir successfully treated by epidural blood patch].
    Jimbo Y; Uzuka T; Fujii Y
    No Shinkei Geka; 2008 Jul; 36(7):639-43. PubMed ID: 18634407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of meningeal carcinomatosis: diagnosis and treatment].
    Nakagawa H; Murasawa A; Nakajima S; Nakajima Y; Izumoto S; Kubo S; Hayakawa T
    No Shinkei Geka; 1992 Jan; 20(1):31-7. PubMed ID: 1738424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of meningeal neoplasms.
    Shapiro WR; Posner JB; Ushio Y; Chemik NL; Young DF
    Cancer Treat Rep; 1977 Jul; 61(4):733-43. PubMed ID: 577896
    [No Abstract]   [Full Text] [Related]  

  • 11. Cerebrospinal fluid pharmacokinetics of intraventricular and intravenous aziridinylbenzoquinone.
    Zimm S; Collins JM; Curt GA; O'Neill D; Poplack DG
    Cancer Res; 1984 Apr; 44(4):1698-701. PubMed ID: 6704975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct administration of methotrexate into the central nervous system of primates. Part 2: Distribution of 3H methotrexate after intrathecal lumbar injection.
    Yen J; Reiss FL; Kimelberg HK; Bourke RS
    J Neurosurg; 1978 Jun; 48(6):895-902. PubMed ID: 96229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active transport of methotrexate from cerebrospinal fluid in humans.
    Bode U; Magrath IT; Bleyer WA; Poplack DG; Glaubiger DL
    Cancer Res; 1980 Jul; 40(7):2184-7. PubMed ID: 7388786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of methotrexate in the cerebrospinal fluid and brain after intraventricular administration.
    Blasberg RG; Patlak CS; Shapiro WR
    Cancer Treat Rep; 1977 Jul; 61(4):633-41. PubMed ID: 406996
    [No Abstract]   [Full Text] [Related]  

  • 15. High-dose methotrexate in acute lymphocytic leukemia.
    Freeman AI; Wang JJ; Sinks LF
    Cancer Treat Rep; 1977 Jul; 61(4):727-31. PubMed ID: 267510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotoxicity and elevated cerebrospinal-fluid methotrexate concentration in meningeal leukemia.
    Bleyer WA; Drake JC; Chabner BA
    N Engl J Med; 1973 Oct; 289(15):770-3. PubMed ID: 4517004
    [No Abstract]   [Full Text] [Related]  

  • 17. [Intrathecal infusion of the antineoplastic agents for meningeal dissemination].
    Hodozuka A; Hayashi Y; Annei R; Hiroshima S; Saito M; Orimoto R; Sato M; Tanaka T
    Gan To Kagaku Ryoho; 2008 Jun; 35(6):900-5. PubMed ID: 18633217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral venous and sinus thrombosis with cerebrospinal fluid circulation block after the first methotrexate administration by lumbar puncture.
    Bienfait HP; Gijtenbeek JM; van den Bent MJ; de Bruin HG; Voogt PJ; Pillay M
    Neuroradiology; 2002 Nov; 44(11):929-32. PubMed ID: 12428129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate. II. Use in pediatric chemotherapy.
    Lippens RJ
    Am J Pediatr Hematol Oncol; 1984; 6(4):397-413. PubMed ID: 6398630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum and cerebrospinal fluid distribution of 5-methyltetrahydrofolate after intravenous calcium leucovorin and intra-Ommaya methotrexate administration in patients with meningeal carcinomatosis.
    Mehta BM; Glass JP; Shapiro WR
    Cancer Res; 1983 Jan; 43(1):435-8. PubMed ID: 6600162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.